History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

SIMPLE SUMMARY: Small cell lung cancer (SCLC) remains the most aggressive form of neuroendocrine tumor of the lung, for which treatment options remain limited. The introduction of immune checkpoint inhibitors has modified for the first time the therapeutic strategies in patients with extensive disea...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Lazzari, Chiara, Mirabile, Aurora, Bulotta, Alessandra, Viganó, Maria Grazia, Ogliari, Francesca Rita, Ippati, Stefania, Dell’Oca, Italo, Santarpia, Mariacarmela, Lorusso, Vincenza, Reck, Martin, Gregorc, Vanesa
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7957518/
https://ncbi.nlm.nih.gov/pubmed/33673630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13050998
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items